Nécrose épidermique toxique traitée par immunoglobulines intraveineuses
- 31 May 2001
- journal article
- other
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 22 (5) , 491-492
- https://doi.org/10.1016/s0248-8663(01)00378-2
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Recent therapeutic advances in dermatology.JAMA, 2000
- Lack of significant treatment effect of plasma exchange in the treatment of drug-induced toxic epidermal necrolysis?Intensive Care Medicine, 1999
- Plasmapheresis as an adjunct treatment in toxic epidermal necrolysisJournal of the American Academy of Dermatology, 1999
- Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysisThe Lancet, 1998
- Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous ImmunoglobulinScience, 1998
- Toxic epidermal necrolysis treated with cyclosporin and granulocyte colony stimulating factorClinical and Experimental Dermatology, 1997
- Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N-acetylcysteineBritish Journal of Dermatology, 1997
- Severe Adverse Cutaneous Reactions to DrugsNew England Journal of Medicine, 1994
- Efficacy of cyclophosphamide in toxic epidermal necrolysisJournal of the American Academy of Dermatology, 1991
- Improved Burn Center Survival of Patients with Toxic Epidermal Necrolysis Managed without CorticosteroidsAnnals of Surgery, 1986